Overview

Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)

Status:
Completed
Trial end date:
2001-07-01
Target enrollment:
Participant gender:
Summary
This study will assess the treatment effect of montelukast versus placebo over a 2 week period in patients with seasonal allergic rhinitis. Loratadine is included in the study as an active comparator.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Loratadine
Montelukast